E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/20/2005 in the Prospect News Biotech Daily.

Connetics maintained by Jefferies at hold

Connetics Corp. was maintained by Jefferies & Co. Inc. analyst David Windley at a hold rating and a $15 price target. The company has a solid franchise but lacks near-term catalysts, Jefferies said. The company lowered guidance for the fourth quarter of 2005 by $6 million to $7 million. Expectations for 2006 reflect about 17% revenue growth and earnings per share of $0.86 to $0.88 a share, below consensus and Jefferies estimates. Shares of the Palo Alto, Calif., specialty pharmaceutical company were up 2 cents, or 0.14%, at $14.48 on volume of 2,205,287 shares versus the three-month running average of 733,951 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.